Volume 10, Number 8—August 2004
Research
Long-Term Prognosis for Clinical West Nile Virus Infection
Anne Labowitz Klee*, Beth Maldin*, Barbara Edwin*, Iqbal Poshni*, Farzad Mostashari*, Annie D. Fine*, Marcelle Layton*, and Denis Nash*†1
Table 6
Recovery at 12 months postonset by health status domain and underlying health condition in patients with clinical West Nile virus infection, New York City, 1999
| Recovery | Total | Recovered, n (%) | Not recovered, n (%) | Risk ratio | 95% confidence interval |
|---|---|---|---|---|---|
| Physical recovery | |||||
| No underlying condition | 18 | 11 (61.1) | 7 (38.9) | 1.3 | 0.70–2.4 |
| Hypertension or diabetes | 17 | 8 (47.1) | 9 (52.9) | Referent | |
| Total | 35 | 19 (54.3) | 16 (45.7) | ||
| Cognitive recovery | |||||
| No underlying condition | 17 | 11 (64.7) | 6 (35.3) | 1.2 | 0.70–2.2 |
| Hypertension or diabetes | 17 | 9 (52.9) | 8 (47.1) | Referent | |
| Total | 34 | 20 (58.8) | 14 (41.2) | ||
| Functional recovery | |||||
| No underlying condition | 18 | 12 (66.7) | 6 (33.3) | 1.4 | 0.78–2.6 |
| Hypertension or diabetes | 17 | 8 (47.1) | 9 (52.9) | Referent | |
| Total | 35 | 20 (57.1) | 15 (42.9) | ||
| Total recovery | |||||
| No underlying condition | 18 | 9 (50.0) | 9 (50.0) | 2.1 | 0.80–5.6 |
| Hypertension or diabetes | 17 | 4 (23.5) | 13 (76.5) | Referent | |
| Total | 35 | 13 (37.1) | 22 (62.9) |
Page created: March 01, 2011
Page updated: March 01, 2011
Page reviewed: March 01, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.